Key metrics and charts across all fundamental categories.
Stock price and market valuation
QGEN closed the most recent quarter at $39.32, a 2.1% decrease year-over-year. Market capitalization stands at $8.22B, down 7.1% from the prior year. Track QGEN price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$2.10B in TTM revenue grew 4.8% YoY, reaching $492.32M last quarter. TTM EBITDA of $694.61M on operating income of $116.63M shows growth is flowing through. Net income of $402.17M TTM confirms the company is converting revenue into profit. Revenue is growing modestly — monitor for acceleration or deceleration.
Assets, cash, debt, and leverage
With $5.78B in assets and $1.65B in long-term debt, the D/E of 0.5 shows a conservative capital structure — the company has a strong financial cushion to weather downturns.
Price multiples and return ratios
At 20.4x P/E, the stock trades in line with market averages — fairly valued. P/S of 3.9x and P/B of 2.5x provide additional context. Assess whether the current multiple is justified by the company's growth and profitability trajectory.
Operating efficiency and return metrics
Op. margin of 23.7% is down 0.2% YoY — costs are rising relative to revenue. Net margin at 13.8%. ROE of 12.1% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $53.75M. The FCF / Net Income ratio of 0.1x indicates partial cash conversion — earnings quality needs attention. Cash reserves of $646.29M provide financial flexibility. Shares outstanding declined 5.1% YoY — buybacks are returning capital to shareholders.
